Straits Times Index
3,273.14 -26.90 (-0.82%) Nikkei
38,460.48 -374.62 (-0.96%) Hang Seng
18,569.54 +90.17 (+0.49%) FTSE 100
8,313.67 +100.18 (+1.22%) Bitcoin USD
62,673.07 -1,104.63 (-1.73%) CMC Crypto 200
1,297.67 -67.46 (-4.94%)
PODD May 2024 180.000 call
| Previous close | 10.03 |
| Open | 11.60 |
| Bid | 13.70 |
| Ask | 14.40 |
| Strike | 180.00 |
| Expiry date | 2024-05-17 |
| Day's range | 11.60 - 14.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 125 |
Business WireInsulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth
ACTON, Mass., May 07, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today released its 2023 Sustainability Report, which describes key accomplishments in environmental, social, and governance (ESG) areas in 2023. The report outlines how the Company’s efforts to focus on sustainability through product accessibility and responsible growth have generated value for our stakeholders.
ZacksAre You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ZacksGear Up for Insulet (PODD) Q1 Earnings: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Insulet (PODD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
